News About: Pharm. Industry
Yuhan's Revanex expected to be in normal supply within this week
Yuhan Corp. says it will address the acute shortage of Revanex (revaprazan) though its normal supply to wholesalers and pharmacies from February 20 at the latest. The company has attributed the shortage problem to eve...
Choong-wae's new payment system kicks off
Choong-wae Pharm has recently announced it will no longer demand a collateral based payment system in a transaction with its associate wholesalers who are facing with collateral problems.
Instead, the company says ...
Medical professionals call for reimbursement of ginkgo biloba preparations
The government needs to withdraw its plan to exclude ginkgo biloba preparations from the health insurance list from May, according to medical experts.
Medical professionals point out that if any unproven alterative...
CJ introduces anti-platelet therapy
CJ Corporation says it has recently launched its Anplate tablets (sarpogrelate HCl), a specific antagonist for 5-HT2A, with hope of acquiring a larger share in the domestic market.
Sarpogrelate has been proven effe...
Shareholders to reap 1.7 billion won, Sewon Cellontech says
Sewon Cellontech shareholders will receive a 1.7 billion won from the company that closed accounts in December.
According to the Financial Supervisory Service, Sewon, which saw 13.2 billion won in net profit on sal...
Debt to capital ratio of 35 drug makers eased in 2006
The debts to capital ratio of 35 KSE-listed pharmaceutical firms in 2006 averaged 61.0 percent an improvement of 3.5 percentage points from 2005 and their debts totaled 2,805 billion won in 2006, according to dat...
Ahngook wins lawsuit over amlodipine
Ahngook Pharm has won the right to market its antihypertensive agent, Levotension (amlopipine besylate S), as the Seoul High Court made its ruling on February 12 that Pfizer's amlodipine patent is null and void, uphol...
Small drug package system to undergo overhaul
The Korea Food and Drug Administration will unveil its plan to ameliorate the controversial small drug package system, under which drug makers are obliged to produce mall-package drugs as much as 10% of the total outp...
Dong-A's unified distribution policy gains favorable market response
Dong-A Pharmaceutical Co. says its unified distribution policy for its five flagship OTC products has gained good response from wholesalers and pharmacists since last month.
The five products include Panpyrine-Q li...
Ethics management issue draws varying reactions
In a recent seminar, the Fair Trade Commission and the Korea Research-based Pharmaceutical Industry Association (KRPIA) disclosed varying views with respect to their approaches to the ethics management of pharmaceutic...
